Evidence map›Paper›PMID 24970491›Full record

ArticleAnnals of epidemiology2014

Declines in coronary heart disease incidence and mortality among middle-aged adults with and without diabetes.

April P Carson, Rikki M Tanner, Huifeng Yun, Stephen P Glasser, J Michael Woolley, Evan L Thacker, Emily B Levitan, Michael E Farkouh, Robert S Rosenson, Todd M Brown and 3 more

Open access · greenAbstract read
In one paragraph

Article in Annals of epidemiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Refining risk in diabetes and CAD with SPECT MPI: New insights and future challenges.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2019
    Article
  8. Article
  9. Mortality Among Black Men in the USA.Journal of racial and ethnic health disparities · 2018
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

April P CarsonDepartment of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham. Electronic address: apcarson@uab.edu.
Rikki M TannerDepartment of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham.
Huifeng YunDepartment of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham.
Stephen P GlasserDepartment of Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham.
J Michael WoolleyCenter for Observational Research, Amgen Inc., Thousand Oaks, CA.
Evan L ThackerDepartment of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham.
Emily B LevitanDepartment of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham.
Michael E FarkouhDepartment of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY; Peter Munk Cardiac Centre and Heart and Stroke Richard Lewar Centre of Excellence, University of Toronto.
Robert S RosensonDepartment of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
Todd M BrownDepartment of Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham.
George HowardDepartment of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham.
Monika M SaffordDepartment of Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham.
Paul MuntnerDepartment of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham; Department of Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham.
University of Alabama at Birmingham · USAmgen (United States) · USIcahn School of Medicine at Mount Sinai · US

Funding

VCID and Stroke in a Bi-racial National CohortU01NS041588 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CUSHMAN, MARY, HOWARD, GEORGE · 2002 to 2022
$96.0M
University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Kirk Michael Habegger · 2013 to 2026
$19.5M
REGARDS - MI StudyR01HL080477 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI LEVITAN, EMILY B, SAFFORD, MONIKA M · 2006 to 2020
$11.6M
Understanding Cohort Effects on Stroke, VCID, and Cognition After Major Epidemiologic TransitionsR01NS041588 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MARY CUSHMAN, VIRGINIA J. HOWARD · 2001 to 2026
$8.8M
Understanding Obesity In Relation to the Built EnvironmentP20MD006899 · NIMHD · JACKSON STATE UNIVERSITY · PI ANTOINE-LAVIGNE, DONNA A · 2012 to 2016
$5.3M
Building Capacity for Cardiometabolic Outcomes ResearchK24HL111154 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI SAFFORD, MONIKA M · 2012 to 2015
$556k
NHLBI NIH HHS K24 HL111154NHLBI NIH HHS R01 HL 080477NHLBI NIH HHS R01 HL080477NIDDK NIH HHS P30 DK079626NIMHD NIH HHS P20 MD006899NINDS NIH HHS R01 NS041588NINDS NIH HHS U01 NS041588
6 · The paper itself

Abstract

purposeThe purpose of the study was to investigate secular changes in coronary heart disease (CHD) incidence and mortality among adults with and without diabetes and to determine the effect of increased lipid-lowering medication use and reductions in low-density lipoprotein cholesterol (LDL-C) levels on these changes.

methodsWe analyzed data on participants aged 45 to 64 years from the Atherosclerosis Risk in Communities Study in 1987-1996 (early period) and the Reasons for Geographic and Racial Differences in Stroke Study in 2003-2009 (late period). Hazard ratios (HRs) for the association of diabetes and period with incident CHD and CHD mortality were obtained after adjustment for sociodemographics cardiovascular risk factors, lipid-lowering medication use, and LDL-C.

resultsAfter multivariable adjustment, diabetes was associated with an increased CHD risk during the early (HR = 1.99, 95% confidence interval = 1.59-2.49) and late (HR = 2.39, 95% confidence interval = 1.69-3.35) periods. CHD incidence and mortality declined between the early and late periods for individuals with and without diabetes. Increased use of lipid-lowering medication and lower LDL-C explained 33.6% and 27.2% of the decline in CHD incidence and CHD mortality, respectively, for those with diabetes.

conclusionsAlthough rates have declined, diabetes remains associated with an increased risk of CHD incidence and mortality, highlighting the need for continuing diabetes prevention and cardiovascular risk factor management.

Indexed as

Cholesterol, LDLComorbidityConfidence IntervalsCoronary DiseaseDiabetes MellitusFemaleFollow-Up StudiesHumansHypolipidemic AgentsIncidenceKaplan-Meier EstimateMaleMiddle AgedModels, StatisticalMultivariate AnalysisProportional Hazards ModelsCholesterol, LDLHypolipidemic AgentsCHDDiabetesEpidemiologyLDL-cholesterol

Identifiers

PMID24970491
PMCPMC4135722
OpenAlexW2080884935

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.